What analysts say about AnaptysBio Inc. stock - Massive wealth growth - Jammu Links News
| ANAB Stock | USD 24.23 0.46 1.86% |
About 62% of AnaptysBio's investor base is looking to short. The analysis of overall sentiment of trading AnaptysBio stock suggests that many investors are alarmed at this time. The current market sentiment, together with AnaptysBio's historical and current headlines, can help investors time the market. In addition, many technical investors use AnaptysBio stock news signals to limit their universe of possible portfolio assets.
AnaptysBio | Build AI portfolio with AnaptysBio Stock |
What analysts say about AnaptysBio Inc. stock - Massive wealth growth Jammu Links News
Read at news.google.com
 |
AnaptysBio Fundamental Analysis
We analyze AnaptysBio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AnaptysBio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AnaptysBio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
AnaptysBio is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
AnaptysBio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AnaptysBio stock to make a market-neutral strategy. Peer analysis of AnaptysBio could also be used in its relative valuation, which is a method of valuing AnaptysBio by comparing valuation metrics with similar companies.
Peers
AnaptysBio Related Equities
| JBIO | Jade Biosciences, | 8.92 | ||||
| CRNX | Crinetics Pharmaceuticals | 3.61 | ||||
| RYTM | Rhythm Pharmaceuticals | 2.20 | ||||
| CGEM | Cullinan Oncology | 1.76 | ||||
| JANX | Janux Therapeutics | 1.49 | ||||
| KURA | Kura Oncology | 0.63 | ||||
| CTMX | CytomX Therapeutics | 0.84 | ||||
| RAPT | RAPT Therapeutics | 6.13 |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |